510(k) Report

510(k) · Cleared

Recalled · 2002

Modification to: Premier Platinum Hpsa

K983255510(k) TraditionalCleared Dec 17, 199893-day reviewClass I21 CFR 866.3110Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Meridian Diagnostics, Inc. · LYR Helicobacter Pylori

Cleared on Dec 17, 1998 after a 93-day review. The FDA summary names its predicate without a number. 10 later devices descend from it. It has been recalled once.

Decided
Dec 17, 1998
Review
93 days
Class
Class I
Product code
LYR
Recalls
1
Predicates
0

10 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared2006: 1 descendant cleared2018: 4 descendants cleared2019: 1 descendant cleared2023: 2 descendants cleared2020: 1 descendant cleared1995200020052010201520202025
  1. This deviceK983255 Modification to: Premier Platinum HpsaMeridian Diagnostics, Inc. · 1998
  2. Descendant · cites it directly · 6 of its ownK053335 Premier Platinum Hpsa Plus, Models 601396, 601480Meridian Bioscience, Inc. · 2006
  3. Descendant · 2 generations on · 3 of its ownK182559 PREMIER Platinum HpSA PLUSMeridian Bioscience, Inc. · 2018
  4. Descendant · cites it directly · 2 of its ownK032222 Immunocardstat HpsaMeridian Bioscience, Inc. · 2003
  5. Descendant · 3 generations on · 0 of its ownK232892 Hp Detect™ Stool Antigen ELISABiomerica, Inc. · 2023
  6. Descendant · 3 generations on · 0 of its ownK230901 Premier HpSA Flex (619096)Meridian Bioscience, Inc. · 2023

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2003: 12006: 12018: 42019: 12020: 12023: 2
2003high 4 (2018) · low 0 (2004)2026

Most influential descendants

Showing 5 of 10 · See all
  • K053335Premier Platinum Hpsa Plus, Models 601396, 601480Meridian Bioscience, Inc. · 2006 · cites it directly6descendants
  • K182559PREMIER Platinum HpSA PLUSMeridian Bioscience, Inc. · 2018 · 2 generations on3descendants
  • K032222Immunocardstat HpsaMeridian Bioscience, Inc. · 2003 · cites it directly2descendants
  • K232892Hp Detect™ Stool Antigen ELISABiomerica, Inc. · 2023 · 3 generations on0descendants
  • K230901Premier HpSA Flex (619096)Meridian Bioscience, Inc. · 2023 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K983255Modification to: Premier Platinum HpsaMeridian Diagnostics, Inc.1998—
+1K053335Premier Platinum Hpsa Plus, Models 601396, 601480Meridian Bioscience, Inc.2006—
+2K182559PREMIER Platinum HpSA PLUSMeridian Bioscience, Inc.2018—
+1K032222Immunocardstat HpsaMeridian Bioscience, Inc.2003—
+3K232892Hp Detect™ Stool Antigen ELISABiomerica, Inc.2023—
+3K230901Premier HpSA Flex (619096)Meridian Bioscience, Inc.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200610
201840
201910
202010
202320
FIG. 1 — Lineage of K983255, 1998–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYR device

  1. #1 K232892 Hp Detect™ Stool Antigen ELISAscore 7.1 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Meretek UBT
Named without a submission number
—

What descends from it? (10)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K053335Premier Platinum Hpsa Plus, Models 601396, 601480Meridian Bioscience, Inc.20066
K032222Immunocardstat HpsaMeridian Bioscience, Inc.20032

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 26, 2002Not classifiedZ-0465-03OtherDue to defective packaging, the firm cannot assure product stability through the labeled expiration date.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K053335 (Meridian Bioscience, Inc., 2006) has gone furthest, with 6 descendants of its own.

How does its category compare?

All LYR devices

LYR Helicobacter Pylori: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LYR

2in 2023

2012: 22015: 22016: 22018: 42019: 12020: 12023: 2
2007high 4 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYR

86in 2018

2018: 86 days median
2007high 86 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYR

2in 2025

2008: 22010: 12022: 32023: 12025: 2
2007high 3 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LYR

2in 2023

2010: 12011: 22015: 22016: 42017: 12020: 42021: 12023: 2
2007high 4 (2016) · low 0 (2007)2025

MAUDE reports naming product code LYR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—20
20090—00
20100—11
20110—02
20122—00
20130—00
20140—00
20152—02
20162—04
20170—01
201848600
20191—00
20201—04
20210—01
20220—30
20232—12
20240—00
20250—20
20260—0—

What is it indicated for?

The Premier Platinum HpSA enzyme immunoassay (EIA) is an in vitro qualitative procedure for the detection of Helicobacter pylori antigens in human stool. Test results are intended to aid in the diagnosis of H. pylori infection, and to monitor response during and post-therapy in adult patients. Accepted medical practice recommends that testing by any current method, to confirm eradication, be done at least four weeks following completion of therapy.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983255: Modification to: Premier Platinum Hpsa.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K983255

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026